A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Evaluation of the Efficacy and Safety of N1539 Following Bunionectomy
Phase of Trial: Phase III
Latest Information Update: 16 Apr 2018
At a glance
- Drugs Meloxicam (Primary)
- Indications Postoperative pain
- Focus Registrational; Therapeutic Use
- Sponsors Recro Pharma
- 16 Apr 2018 According to a Recro Pharma media release, data from this trial will be presented at the 43rd Annual Regional Anesthesiology and Acute Pain Medicine Meeting co-hosted by the American Society of Regional Anesthesia and Pain Medicine (ASRA).
- 27 Mar 2018 Results presented in a Recro Pharma media release.
- 27 Mar 2018 According to a Recro Pharma media release, results were published online in the Clinical Journal of Pain.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History